NeuroOne Promotes Emily Johns to Chief Administrative Officer Role

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), a pioneering medical technology company focused on neurological disorders, has announced the significant promotion of Emily Johns to the expanded role of Chief Administrative Officer and General Counsel. This strategic move comes after Johns joined the company earlier this year as General Counsel and has already made what CEO Dave Rosa describes as "impactful contributions" to the organization's future growth. The promotion represents a vote of confidence in Johns' leadership capabilities as she now takes on additional responsibilities overseeing human resources, compliance, security, and risk management across the organization while continuing to lead NeuroOne's legal strategy.

Johns brings substantial experience to her expanded role, having previously served as a partner at Honigman LLP where she represented numerous life sciences companies, including NeuroOne on all transactional work since 2017. Her career began at the prestigious Sullivan & Cromwell LLP, where she represented public companies in securities offerings and M&A transactions. In her statement, Johns expressed honor at stepping into this expanded position and emphasized her commitment to "strengthening our operations and infrastructure to help bring our life-changing technologies to more people." The announcement was distributed through NEWMEDIAWIRE, a platform known for corporate communications, and the company maintains its investor relations contact through MZ Group.

NeuroOne is developing groundbreaking minimally invasive and hi-definition solutions for EEG recording, stimulation, and ablation treatments targeting serious neurological conditions including epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain resulting from failed back surgeries. The company's innovative approach aims to improve patient outcomes while reducing procedural costs, and they're exploring expansion into other medical areas such as depression, mood disorders, pain management, incontinence, high blood pressure, and artificial intelligence applications. Interested parties can find additional information through the company's official website at www.nmtc1.com, which serves as a comprehensive resource for understanding NeuroOne's mission and technological advancements in neurological care.